WFDC2 and neoplasm: A study completed by Lu et al. in 2015 [25] showed that treatment with human HE4 recombinant active protein increased the viability and proliferation of pancreatic and endometrial cancer cells, and that cell lines with highly expressed levels of HE4 caused subcutaneous tumor formation in nude mice.